Tag: biomedical
-
Genetic Repair Company Starts-Up, Gains $87 Million
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA.
-
You Call That a Drug Pricing Policy?
Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that.
-
Mobile App Helps Screen for Substance Abuse
A mobile app written for computer tablets was designed by a New York medical center to help clinicians screen patients for signs of addiction or substance abuse, and refer individuals for treatment.
-
Crispr Deployed to Correct Inherited Vision Disorder
Researchers at Columbia University developed and tested in lab mice a technique using the genome editing technology Crispr with gene replacement therapy to correct the inherited eye disease retinitis pigmentosa.
-
University, Industry Labs Partner on Bioprinted Tissue
A joint project between Indiana University and the company Lung Biotechnology is investigating three-dimensional bioprinting to produce animal tissue for research on organ transplantation, and eventually for transplants themselves.
-
Computer-Designed Heart Valves Operate Over Long Term
A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation.
-
Genentech Gains Microbe Drug Discovery Tech in $1B Deal
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil.
-
Crowdfunding Found Supporting Dubious Stem Cell Clinics
More people now use crowdfunding campaigns to raise money to cover families’ medical costs, but the technique is also used to support treatments from stem cell clinics that exaggerate their outcomes and minimize their risks.
-
Univ. Spinoff Qualifies for NIH Clinical Program
An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials.
-
3-D Models Devised to Simulate Patients’ Tumors
A university lab is teaming up with a local biotechnology company to develop realistic models of tumors from individual cancer patients, enabling more personalized treatment options.